About MedImmune

  • >120 biologics in R&D
  • ~2,200 global employees
  • 50% of AstraZeneca's pipeline

Leading global biologics R&D

With one of the largest, most robust pipelines in the industry — including more than 120 research projects and product candidates — we comprise nearly half of AstraZeneca’s overall R&D portfolio. We are focused on three core therapeutic areas: Oncology; Respiratory, Inflammation and Autoimmune; and Cardiovascular and Metabolic Disease. But, we also are opportunity-driven in Infectious Disease.

Rich history, promising future

A history of MedImmune

Fostering Innovation


United Kingdom

In addition to having more than 600 employees, MedImmune, Cambridge, has strong collaborative links with numerous academics, researchers, foundations and neighboring companies in Europe's largest biotech cluster.

Gaithersburg, MD

United States

A modern and vibrant science campus employs more than 2,000 industry experts and sits amid a strong and growing biotech hub–and is only a short drive from Washington, DC.

South San Francisco

United States

Our state-of-the-art facility in the Cove at Oyster Point is located in the heart of the Bay Area’s vibrant biotechnology and technology community.

MedImmune on Instagram

Follow us on Twitter

Our commitment to Sustainability